Skip to main content

HCC 18: Cancer Metastatic to Bone, Other and Unspecified Metastatic Cancer; Acute Leukemia Except Myeloid

HCC 18, Cancer Metastatic to Bone, Other and Unspecified Metastatic Cancer; Acute Leukemia Except Myeloid, is one of the 115 payment categories in the CMS-HCC V28 model. 26 ICD-10-CM codes map to it in the payment year 2027 mapping, and a documented diagnosis in the category adds a relative factor of 2.341 to the risk score of a community, non-dual, aged beneficiary (2.486 disabled, 1.110 institutional). It is overridden when a more severe category in its hierarchy is present (HCC 17) and it in turn overrides HCC 19, HCC 20, HCC 21, HCC 22, HCC 23. In its hierarchy, HCC 17 overrides it when both are coded, at a community aged factor of 4.209 (+1.868), and it overrides HCC 19 (1.798, -0.543), so a record coding both is paid this category's factor alone.

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: ICD-10-CM to HCC mapping: PY2027 initial ICD-10-CM mappings (dates of service 2026) (payment year 2027); CMS-HCC V28 model software: CMS-HCC V28 software V2826.115.T2 (PY2027 initial) (payment year 2027). Next CMS release: PY2028 advance notice (February 2027) and the PY2027 midyear final mapping (spring 2027).

Mapped ICD-10-CM codes
26
Factor, community non-dual aged
2.341
Factor, institutional
1.110
Hierarchy
Overridden by HCC 17
Disease group
Neoplasm

Relative factors by segment

Each segment is a separate regression; the factor is added to the beneficiary's demographic factors and other categories, then normalized and reduced by the coding intensity adjustment before it meets the plan's base rate. A factor of 1.000 equals the expected cost of an average beneficiary.

CMS-HCC V28 relative factors for HCC 18 by model segment
SegmentModel codeRelative factor
Community, non-dual, agedCNA_HCC182.341
Community, non-dual, disabledCND_HCC182.486
Community, full-benefit dual, agedCFA_HCC182.277
Community, full-benefit dual, disabledCFD_HCC182.537
Community, partial-benefit dual, agedCPA_HCC182.166
Community, partial-benefit dual, disabledCPD_HCC182.403
Long-term institutionalINS_HCC181.110

Hierarchy

Hierarchical condition categories pay only the most severe manifestation of a disease. When HCC 17 (Cancer Metastatic to Lung, Liver, Brain, and Other Organs; Acute Myeloid Leukemia Except Promyelocytic) is also documented for the same beneficiary, HCC 18 is dropped from the score. When HCC 18 is present it drops HCC 19 (Myelodysplastic Syndromes, Multiple Myeloma, and Other Cancers), HCC 20 (Lung and Other Severe Cancers), HCC 21 (Lymphoma and Other Cancers), HCC 22 (Bladder, Colorectal, and Other Cancers), HCC 23 (Prostate, Breast, and Other Cancers and Tumors), so documenting the less severe condition alongside it adds nothing to payment but still matters for the clinical record.

ICD-10-CM codes that map to HCC 18

26 codes map to this category in the PY2027 initial mapping, concentrated in the C79 (14), C77 (5), C91 (3), C95 (3), C80 (1) code families. CMS built that mapping from codes valid in FY2025 and FY2026, and descriptions are the CMS mapping descriptions. None of these codes was deleted in the October 1, 2026 update.

ICD-10-CM codes mapped to HCC 18 in the CMS PY2027 initial mapping
ICD-10-CMDescription
C77.0Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck
C77.2Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes
C77.4Secondary and unspecified malignant neoplasm of inguinal and lower limb lymph nodes
C77.5Secondary and unspecified malignant neoplasm of intrapelvic lymph nodes
C77.9Secondary and unspecified malignant neoplasm of lymph node, unspecified
C79.10Secondary malignant neoplasm of unspecified urinary organs
C79.11Secondary malignant neoplasm of bladder
C79.19Secondary malignant neoplasm of other urinary organs
C79.2Secondary malignant neoplasm of skin
C79.51Secondary malignant neoplasm of bone
C79.52Secondary malignant neoplasm of bone marrow
C79.60Secondary malignant neoplasm of unspecified ovary
C79.61Secondary malignant neoplasm of right ovary
C79.62Secondary malignant neoplasm of left ovary
C79.63Secondary malignant neoplasm of bilateral ovaries
C79.81Secondary malignant neoplasm of breast
C79.82Secondary malignant neoplasm of genital organs
C79.89Secondary malignant neoplasm of other specified sites
C79.9Secondary malignant neoplasm of unspecified site
C80.0Disseminated malignant neoplasm, unspecified
C91.00Acute lymphoblastic leukemia not having achieved remission
C91.01Acute lymphoblastic leukemia, in remission
C91.02Acute lymphoblastic leukemia, in relapse
C95.00Acute leukemia of unspecified cell type not having achieved remission
C95.01Acute leukemia of unspecified cell type, in remission
C95.02Acute leukemia of unspecified cell type, in relapse

New FY2027 codes in this family (CMS mapping pending)

The October 1, 2026 update created 1 code for conditions that were previously reported with a code mapping to HCC 18; the FY2027 conversion table names that earlier code in the last column. CMS has not mapped the new codes yet, because the PY2027 initial mapping only covers codes valid in FY2025 and FY2026, so treat their category as pending until CMS posts a mapping that includes FY2027 codes.

ICD-10-CM codes new on October 1, 2026 whose predecessor maps to HCC 18
New ICD-10-CMDescriptionPreviously coded as
C79.83Secondary malignant neoplasm of oral cavityC79.89

Every new and deleted code for FY2027, with its CC level and MS-DRGs, is in the FY2027 ICD-10-CM/PCS code changes report.

What changed from V24

The payment year 2025 mapping carries both models for the same codes. Of the 26 codes it maps to V28 HCC 18, every one already paid under V24; the largest source is V24 HCC 8 (Metastatic Cancer and Acute Leukemia) with 22 codes. The V28 community, non-dual, aged factor is 2.341 against 2.659 for V24 HCC 8.

V24 categories that the HCC 18 codes belonged to (PY2025 mapping)
V24 HCCV24 categoryCodes now in HCC 18V24 codes with no V28 HCCV24 factor (CNA)
8Metastatic Cancer and Acute Leukemia220 of 822.659
10Lymphoma and Other Cancers40 of 5950.675

V24 and V28 number their categories independently, so the same diagnosis usually carries a different HCC number in each model. The V24 to V28 crosswalk report lists every category pair, and the glossary explains the 2020 CMS-HCC V24 model and the V28 model that replaced it.

Inpatient groups where these diagnoses land

Appendix B of the v44 MS-DRG Definitions Manual places the codes in this category in the logic of 55 MS-DRGs. The groups with the most shared codes are below; a hospital stay coded with one of these diagnoses groups there when it is the principal diagnosis, or when the DRG's logic uses it as a qualifying secondary diagnosis.

MS-DRGs whose logic lists the most HCC 18 codes
MS-DRGTitleShared codes
DRG 820Lymphoma and Leukemia with Major O.R. Procedures with MCC11
DRG 821Lymphoma and Leukemia with Major O.R. Procedures with CC11
DRG 822Lymphoma and Leukemia with Major O.R. Procedures without CC/MCC11
DRG 834Acute Leukemia with MCC6
DRG 835Acute Leukemia with CC6
DRG 836Acute Leukemia without CC/MCC6
DRG 837Chemotherapy with Acute Leukemia as Secondary Diagnosis or with High Dose Chemotherapy Agent with MCC6
DRG 838Chemotherapy with Acute Leukemia as Secondary Diagnosis with CC or High Dose Chemotherapy Agent6
DRG 839Chemotherapy with Acute Leukemia as Secondary Diagnosis without CC/MCC6
DRG 850Acute Leukemia with Other Procedures6

Local coverage policies that list these diagnoses

Medicare Administrative Contractors name covered ICD-10-CM codes in the billing and coding articles attached to their LCDs. These policies share the most codes with HCC 18 in the current Medicare Coverage Database export (one policy per topic; overlap counts after each). For the services these policies govern, the same diagnoses are covered indications, so the documentation that supports the category also supports the claim for the service.

Where these codes sat in the V22 model

The V28 recalibration renumbered and regrouped categories; this table shows which legacy V22 categories the same ICD-10 codes belonged to, which is the quickest way to reconcile a V22-era HCC gap list with the current model.

V22 categories that the HCC 18 codes mapped to
V22 HCCCodes
822
104

Part D: the RxHCC categories of these codes

The same diagnoses feed the RxHCC model, which adjusts Medicare Part D payments. Of the 26 codes in HCC 18, 26 also map to a prescription drug category; the categories are below, and the RxHCC hub has their 2027 MA-PD, PDP and PACE factors.

RxHCC V08 categories that the HCC 18 codes map to
RxHCCCategoryCodes
RxHCC 18Secondary Cancer of Lung, Liver, Brain, and Other Sites12
RxHCC 19Leukemias and Other Hematologic Cancers6
RxHCC 20Lung, Kidney, and Other Cancers; Secondary Cancer of Lymph Nodes and Other Sites6
RxHCC 17Secondary Cancer of Bone and Kidney2

Capturing and defending the category

A category counts for a payment year when a mapped diagnosis is documented at least once during the data collection year by an acceptable provider type at a face-to-face or audio-video encounter, and when the note shows the condition was monitored, evaluated, assessed or treated. Chronic conditions do not carry forward: a category that is not re-documented in the year drops out of the score, which is why annual wellness visits and problem-list reconciliation are where most recapture happens. Risk adjustment data validation audits sample enrollees and ask for the medical record behind each submitted category; an unsupported category is removed and, under the extrapolation rules, the error rate is applied across the contract. The QuickIntell risk adjustment product surfaces suspected and unsupported categories from the chart, and the HCC hub lists every V28 category with its factor and code count.

For teams evaluating QuickIntell software

Evaluate risk adjustment review software

For teams reviewing documentation across a cohort, explore source evidence, proposed findings, reviewer decisions and audit handoffs. Confirm the program, payment year and model scope during evaluation. A category lookup is not a patient-specific coding or payment determination.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions

Which ICD-10 codes map to HCC 18?

26 ICD-10-CM codes map to HCC 18 in the CMS PY2027 initial mapping, for example C77.0 Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck; C77.2 Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes; C77.4 Secondary and unspecified malignant neoplasm of inguinal and lower limb lymph nodes; C77.5 Secondary and unspecified malignant neoplasm of intrapelvic lymph nodes. The full list is on this page; a code counts only when it is documented at a face-to-face or video encounter in the data collection year and supported by the record.

How much does HCC 18 add to a risk score?

The V28 relative factor for HCC 18 is 2.341 for a community, non-dual, aged beneficiary, 2.277 for full-benefit dual aged, 2.486 for non-dual disabled and 1.110 for long-term institutional members. A factor of 1.000 equals the expected annual cost of an average beneficiary, so the category's share of the payment follows the plan's base rate for that segment.

Does HCC 18 count together with related categories?

No. Within a hierarchy only the most severe category is paid. HCC 18 is dropped when HCC 17 (Cancer Metastatic to Lung, Liver, Brain, and Other Organs; Acute Myeloid Leukemia Except Promyelocytic) is also present, and it drops HCC 19, HCC 20, HCC 21, HCC 22, HCC 23 when it is present.

What has to be documented for HCC 18 to be valid?

One of the 26 mapped codes (such as C77.0) must be recorded by an acceptable provider type during a face-to-face or audio-video encounter in the service year, with the note showing that the condition (Cancer Metastatic to Bone, Other and Unspecified Metastatic Cancer; Acute Leukemia Except Myeloid) was monitored, evaluated, assessed or treated. Risk adjustment data validation audits recover payment for categories the record does not support, so the code on the claim and the assessment in the note must match.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

Relative factors and mappings are reproduced from the CMS risk adjustment model files as an operational reference. Payment depends on the plan's base rate, normalization, the coding intensity adjustment and the enrollee's segment. Not legal, clinical or billing advice.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.